Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 May 1;10(5):499-502.
doi: 10.1242/dmm.030205.

Neurodegenerative disease: models, mechanisms, and a new hope

Affiliations
Editorial

Neurodegenerative disease: models, mechanisms, and a new hope

Aaron D Gitler et al. Dis Model Mech. .

Abstract

Neurodegeneration is a feature of many debilitating, incurable diseases that are rapidly rising in prevalence, such as Parkinson's disease. There is an urgent need to develop new and more effective therapeutic strategies to combat these devastating diseases. Models - from cell-based systems, to unicellular organisms, to complex animals - have proven to be a useful tool to help the research community shed light on the mechanisms underlying neurodegenerative diseases, and these advances have now begun to provide promising therapeutic avenues. In this themed issue of Disease Models & Mechanisms, a special collection of articles focused on neurodegenerative diseases is introduced. The collection includes original research articles that provide new insights into the complex pathophysiology of such diseases, revealing candidate biomarkers or therapeutic targets. Some of the articles describe a new disease model that enables deeper exploration of key mechanisms. We also present a series of reviews that highlight some of the recent translational advances made in studies of neurodegenerative diseases. In this Editorial, we summarize the articles featured in this collection, emphasizing the impact that model-based studies have made in this exciting area of research.

PubMed Disclaimer

References

    1. Abeliovich A. and Gitler A. D. (2016). Defects in trafficking bridge Parkinson's disease pathology and genetics. Nature 539, 207-216. 10.1038/nature20414 - DOI - PubMed
    1. Annesley S. J., Lay S. T., De Piazza S. W., Sanislav O., Hammersley E., Allan C. Y., Francione L. M., Bui M. Q., Chen Z.-P., Ngoei K. R. W. et al. (2016). Immortalized Parkinson's disease lymphocytes have enhanced mitochondrial respiratory activity. Dis. Model. Mech. 9, 1295-1305. 10.1242/dmm.025684 - DOI - PMC - PubMed
    1. Armakola M., Higgins M. J., Figley M. D., Barmada S. J., Scarborough E. A., Diaz Z., Fang X., Shorter J., Krogan N. J., Finkbeiner S. et al. (2012). Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models. Nat. Genet. 44, 1302-1309. 10.1038/ng.2434 - DOI - PMC - PubMed
    1. Auluck P. K., Chan H. Y., Trojanowski J. Q., Lee V. M. and Bonini N. M. (2002). Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. Science 295, 865-868. 10.1126/science.1067389 - DOI - PubMed
    1. Baldassarro V. A., Marchesini A., Giardino L. and Calzà L. (2017). Vulnerability of primary neurons derived from Tg2576 Alzheimer mice to oxygen and glucose deprivation: role of intraneuronal amyloid-β accumulation and astrocytes. Dis. Model. Mech. 10, 671-678. 10.1242/dmm.028001 - DOI - PMC - PubMed

Publication types